Utility of the ‘surprise question’ in a day therapy palliative care practice; should specialist palliative care be focusing on total symptom burden and complexity rather than prognostication?: table 1 by Gishen, F et al.
UTILITY OF THE ‘SURPRISE QUESTION’ IN A DAY THERAPY PALLIATIVE CARE 
PRACTICE; SHOULD SPECIALIST PALLIATIVE CARE BE FOCUSING ON TOTAL 
SYMPTOM BURDEN AND COMPLEXITY RATHER THAN PROGNOSTICATION? 
1. F Gishen1,2⇓,  
2. J Eades1 and  
3. A Tookman1 
Abstract 
Introduction There is recognition that the nature of palliative care may be changing, 
as cancer survival improves and long-term conditions increase the complexity of the 
case load. Previous work has examined the accuracy of expert prognostication in 
patients with a life expectancy of less than a year. This piece of work also considers 
the accuracy of prognostication in patients thought to have a longer prognosis, and 
who may therefore be largely excluded from referral to specialist palliative care 
services, based on current referral patterns. It questions whether the palliative care 
net should be widened to reflect uncertainties in prognostication, and thereby 
extend valuable end of life services to a broader range of patients. 
Aim(s) and method(s) A ‘snapshot’ cohort of the total number of patients accessing 
a palliative care day therapy unit on a given date was taken. Patients were 
categorised into the groups below using the ‘Surprise Question’ (Gold Standards 
Framework) by two experts in Palliative Care (one clinical nurse specialist/ one 
physician) and triple-read by a second palliative care consultant. End of life 
care=likely to have less than 12 month prognosis (malignant & non-malignant 
diagnoses). Cancer Survivorship= malignant diagnosis with a probable life 
expectancy of greater than 12 months. Non Malignant Survivorship=Patient has a 
non-malignant diagnosis with a probable life expectancy of greater than 12 months. 
The patient group was re-analysed one year later, to assess the accuracy of 
prognostication. 
Results See Abstract P 37 Table 1. 
Table 1 
Conclusion(s) Our end of life predictions mirror other studies for those patients 
predicted to have a life expectancy of less than one year. We have also 
demonstrated that the cancer survivorship population (ie greater than 12 months 
life expectancy) had higher than predicted mortality rates within the first year. Is the 
surprise question an optimal tool? Does the surprise question promote ‘cherry 
picking’; should specialist palliative care be focusing on total symptom burden and 
complexity rather than prognostication? 
